Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices – Market Insights – Eastern Europe

With the impact of, and recovery from, the COVID-19 pandemic coming to an end, the EE IC device market will shortly witness a return to prepandemic growth trends by 2024. Shifting preference toward several new approaches, such as FFR, IVUS, DCBs for complex PCIs, specialty balloons, and radial access approaches, along with new positive clinical, will fuel market growth in the Eastern European IC device market, thus impacting the position of the current market leaders going forward.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IC devices in Europe from 2019 through 2032.

The DES segment is a highly competitive space, with the leading companies continuing to launch updates to their flagship devices.

Has there been any change in position between the three major competitors in the highly lucrative DES device market?

What are the competitive strategies companies are trying to gain market shares over their rivals?

How is the penetration of DES changing over the covered geographies?

How will BRS development impact the coronary stent market over the forecast period?

Emerging technologies designed to diagnose and treat complex PCIs will influence the IC device market landscape in Eastern Europe.

How are DCBs going to be adopted going forward?

How the existing products are performing in combination? How is this affecting the physicians in their ability to treat specific cases?

What is the impact of the latest generation of alternative coronary physiology modalities such as resting index or imaging-based FFRangio and FFRCT on the patient and procedure in cardiac catheterization labs?

How will recent clinical evidence impact the adoption of IVUS and OCT?

How will the emergence of alternative FFR modalities affect the FFR pressure guidewire market?

What is the status and expected impact of emerging techniques like coronary lithotripsy?

How will this impact the small and mid-sized emerging companies in the IC device market?

The European IC device market has been impacted by the COVID-19 pandemic.

What is the recovery outlook for 2022 and going forward?

To what degree has the pandemic affected different procedures and devices?

Table of contents


Related Medtech Insights Reports

Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Varicose Vein Treatment Devices – Market Insights – United States
The US varicose vein treatment device market will be driven by the continued shift toward minimally invasive procedures and the evolving reimbursement landscape supporting endovenous ablation and…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…